This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US FTC says separate trials in PBM antitrust case would be 'wasteful'

( November 4, 2024, 23:31 GMT | Official Statement) -- MLex Summary: The US Federal Trade Commission opposed pharmacy benefit managers’ request for separate hearings in an administrative lawsuit alleging anticompetitive conduct that pressured drugmakers to hike list prices of insulin to maximize profits. “This is not a case where complaint counsel seeks to consolidate separate, unrelated cases into a single hearing. To the contrary, from the beginning, the respondents were investigated collectively because they engaged in common patterns of conduct that are now subject to common proof in litigation. In circumstances as these, ‘it would be wasteful to conduct three separate trials,’” the FTC said. See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections